The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...

The advisory panel to the Centers for Disease Control and Prevention had made recommendations regarding the use of separate ...

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

Bavarian Nordic is targeting launch of the vaccine in the UK during the summer of 2025. “Chikungunya mostly represents a risk for UK citizens traveling overseas to affected regions in the Americas, ...

As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults. | France’s public health agency has temporarily ...

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...

Copenhagen, Denmark Saturday, May 3, 2025, 12:00 Hrs [IST] ...